{"prompt": "['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', 'Any study medication discontinuation or dose reduction during the up-titration', '(days 1 to 6)', 'Study medication discontinuation (i.e. no study medication taken) during the', 'maintenance phase irrespective of the reason for more than 5 days in a row or a', 'total of 10 days, or dose reduction (i.e. 1 tablet per day) during the maintenance', 'phase (from day 6 onwards) irrespective of the reason for more than 5 days in a', 'row or a total of 10 days', 'Major protocol violation (e.g. patient requires the use of medication and / or', 'treatments not permitted by the study protocol)', 'Severe treatment emergent adverse events that in the opinion of the investigator', 'results in a risk / benefit assessment with negative results', 'Patients are also to be withdrawn at any time if the investigator concludes that it', \"would be in the patient's best interest for any reason\", 'Depression worsening under treatment', 'Patients are to be considered withdrawn if they state an intention to withdraw, fail to return for', 'visits, become lost to follow up for any other reason, or if any of the following occur: discovery', 'of patient ineligibility; errors in treatment compliance; missed or incorrect assessments.', \"Protocol violations do not necessarily lead to the patient's withdrawal unless they constituted\", \"a significant risk to the patient's safety. For patients not completing the entire study, all used\", 'and unused study drug should be returned by the patients to the defined personnel at the site.', 'Patients who prematurely withdraw from the study will be scheduled for an end-of-study visit', 'as soon as possible (11.2.6). An end-of-study page will be completed, giving the date and', 'primary reason for stopping treatment if provided. Patients prematurely withdrawn from the', 'study will not be replaced. Patients who prematurely withdraw from the study for any reason', 'at any time are excluded from the continuation of the study and will be treated if indicated as', 'for any event still ongoing at the end of a clinical study according to standard practice under', 'supervision by an experienced dermatologist or will be referred to a dermatologic practice for', 'further treatment according to standard practice. In the case of premature discontinuation due', 'to an adverse event (AE), the investigator should ensure that the patient receives a suitable', 'therapy appropriate to his / her conditions.', 'For patients who are lost to follow-up (i.e., those patients whose status is unclear because they', 'fail to appear for study visits without stating an intention to withdraw), the investigator should', 'show due diligence by documenting in the source documents steps taken to contact the', 'patient, e.g., dates of telephone calls, registered letters, etc.', '8.5', 'Discontinuation of Entire Study', 'The study must be terminated prematurely for the following reason(s)', \"Updated risk / benefit assessment with negative results (sponsors' and\", \"coordinating investigators' assessment)\", 'Study cannot be completed within a reasonable time frame due to slow patient', 'recruitment', 'The regulatory authorities and the Institutional Review Board (IRB) / Independent Ethics', 'Committee (IEC) must be notified of premature termination of the study. The investigator may', 'Page 27 of 75']['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', 'be informed of additional procedures to be followed in order to assure that adequate', \"consideration is given to the protection of the patient's interests.\", 'In addition, a site may be discontinued at any time by the sponsor and all study materials', 'removed. Possible reasons for termination of the study at the site include, but are not limited', 'to:', 'Safety concerns based on reported data', 'Unsatisfactory enrolment with respect to quantity or quality', 'Inaccurate or incomplete data collection', 'Falsification of records', 'Failure to adhere to the protocol', 'Page 28 of 75']\n\n###\n\n", "completion": "END"}